SCHEMBL4074979

SCHEMBL4074979

c1ccc(/N=C2\N/C(=N/c3ccccn3)c3cc4ccccc4cc32)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.38
HSD17B10 Q99714 3/20 0.38
ALDH1A1 P00352 3/20 0.38
ADRA2A P08913 2/20 0.38
ADRA2B P18089 2/20 0.38
ADRA2C P18825 2/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
PLAU P00749 1/20 0.38
MAPK1 P28482 3/20 0.37
TP53 P04637 2/20 0.37
TSHR P16473 2/20 0.37
ALOX15 P16050 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.36
KDM4E B2RXH2 3/20 0.36
LMNA P02545 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
OPRK1 P41145 2/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4074981 1.00 MAPT (0.38) MAPTHSD17B10ALDH1A1ADRA2AADRA2B
SCHEMBL21715832 1.00 MAPT (0.38) MAPTHSD17B10ALDH1A1ADRA2AADRA2B
SCHEMBL3968881 0.85 HSD17B10 (0.44) MAPTHSD17B10ALDH1A1ADRA2AADRA2B
SCHEMBL3968879 0.85 HSD17B10 (0.44) MAPTHSD17B10ALDH1A1ADRA2AADRA2B
SCHEMBL9976117 0.85 HSD17B10 (0.44) MAPTHSD17B10ALDH1A1ADRA2AADRA2B
SCHEMBL31493860 0.85 HSD17B10 (0.44) MAPTHSD17B10ALDH1A1ADRA2AADRA2B
SCHEMBL4402093 0.84 HSD17B10 (0.43) MAPTHSD17B10ALDH1A1ADRA2AADRA2B
SCHEMBL4402096 0.84 HSD17B10 (0.43) MAPTHSD17B10ALDH1A1ADRA2AADRA2B
SCHEMBL4405611 0.84 HSD17B10 (0.43) MAPTHSD17B10ALDH1A1ADRA2AADRA2B
SCHEMBL4405615 0.84 HSD17B10 (0.43) MAPTHSD17B10ALDH1A1ADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090243468-A1 ARYLIMINO-ISOINDOLINE COMPLEXES FOR USE IN ORGANIC LIGHT EMITTING DIODES THE UNIVERSITY OF SOUTHERN CALIFORNIA 2009-10-01 US disclosed
WO-2009052268-A1 ARYLIMINO-ISOINDOLINE COMPLEXES FOR USE IN ORGANIC LIGHT EMITTING DIODES UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2009-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090243468-A1 ARYLIMINO-ISOINDOLINE COMPLEXES FOR USE IN ORGANIC LIGHT EMITTING DIODES BRI3BP, PPOX, MAP1LC3C MAPT 288/4885HSD17B10 4209/4885ALDH1A1 486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.